TRANSLATE-TIMI 70

TRANSLATE-TIMI 70 is a phase 2b trial testing multiple doses of vupanorsen, an antisense oligonucleotide (ASO) against angiopoietin-like 3 (ANGPTL3) mRNA, for safety and efficacy in non-HDL-C lowering.

TRANSLATE Schema 2020-9-30

TRANSLATE on ClinicalTrials.gov

CONTACT US about TRANSLATE

%d bloggers like this:
search previous next tag category expand menu location phone mail time cart zoom edit close